Fig. 3From: Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancerOverall survival in pT3 or higher stage prostate cancer. DDR pathway alteration was associated with a shorter overall survival in patients with pT3 or higher stage prostate cancerBack to article page